Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer-Reference-Cited by-同舟云学术

Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer

Published:2011-06-08 Issue:8 Volume:3 Page:451-464
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Soon Wendy WeiJia¹,Miller Lance David²,Black Michael A.³,Dalmasso Cyril⁴,Chan Xiu Bin¹,Pang Brendan⁵,Ong Chee Wee⁶,Salto‐Tellez Manuel⁵⁶,Desai Kartiki V.¹,Liu Edison T.¹

Affiliation:

1. Cancer Biology and Pharmacology, Genome Institute of Singapore, Singapore

2. Department of Cancer Biology, Wake Forest University School of Medicine, Winston‐Salem, USA

3. Department of Biochemistry, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand

4. Computational and Mathematical Biology, Genome Institute of Singapore, Singapore

5. Department of Pathology, National University Health System and National University of Singapore, Singapore

6. Cancer Science Institute, National University of Singapore, Singapore

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201100150

Reference45 articles.

1. Therapeutic Targeting of SPINK1-Positive Prostate Cancer

2. The SPINK1 N34S variant is associated with acute pancreatitis

3. Translating insights from the cancer genome into clinical practice

4. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

5. TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High expression of serine protease inhibitor kazal type 1 predicts poor prognosis and promotes the progression and invasion of oral tongue squamous cell carcinoma;Archives of Oral Biology;2024-08

2. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC);Diagnostics;2024-03-29

3. Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer;Breast Cancer Research and Treatment;2023-12-01

4. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma;Nature Communications;2023-11-29

5. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine;Human Cell;2022-09-02